SCHEMBL7801637

SCHEMBL7801637

CCCCOC(=O)NCc1ccccc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
HSD17B10 Q99714 2/20 0.55
KDM4E B2RXH2 3/20 0.49
POLB P06746 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
LMNA P02545 3/20 0.48
TSHR P16473 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HPGD P15428 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2C19 P33261 3/20 0.46
RCE1 Q9Y256 1/20 0.46
HDAC1 Q13547 1/20 0.44
ACHE P22303 6/20 0.44
CYP2C9 P11712 2/20 0.44
CYP3A4 P08684 1/20 0.43
PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11089043 0.84 HPGD (0.51) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL3416627 0.83 RIPK1 (0.52) ALDH1A1SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL6498349 0.82 TSHR (0.60) ALDH1A1KDM4ERAB9ANPC1TSHR
SCHEMBL11472039 0.82 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL17773307 0.81 RAB9A (0.47) SMN1; SMN2RAB9ANPC1LMNATSHR
SCHEMBL15738726 0.81 SMN1; SMN2 (0.46) ALDH1A1SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL28593323 0.80 NPC1 (0.58) ALDH1A1SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL8568942 0.80 HPGD (0.57) ALDH1A1HSD17B10KDM4ERAB9ANPC1
SCHEMBL3806762 0.79 EPHX2 (0.56) ALDH1A1POLBSMN1; SMN2RAB9ANPC1
SCHEMBL7799195 0.79 SMN1; SMN2 (0.51) ALDH1A1POLBSMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163220-A1 TRICYCLIC INDOLE-2-CARBOXYLIC ACID COMPOUND USED AS NMDA RECEPTOR ANTAGONIST SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-12-19 EP disclosed
WO-2000056711-A1 TRICYCLIC INDOLE-2-CARBOXYLIC ACID COMPOUND USED AS NMDA RECEPTOR ANTAGONIST SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2000-09-28 WO disclosed